Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Noah Doyle currently holds 704,780 shares of RITTER PHARMACEUTICALS INC (RTTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Noah Doyle has been a net buyer of RTTR stock. They have purchased $4.0M and sold $110.0K worth of shares.
Noah Doyle's most recent insider trade was on Mar 12, 2020, when they sold 500,000 shares at $0.22 per share.
Noah Doyle serves as Executive at RITTER PHARMACEUTICALS INC (RTTR). They have executed 6 insider transactions totaling $4.1M over their tenure at the company.
Noah Doyle holds the position of Executive at RITTER PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Noah Doyle has shown a buying trading pattern, with $4.0M in total purchases and $110.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Noah Doyle was on Jun 24, 2015, when they purchased $4.0M worth of RTTR shares. This transaction involved 800,000 shares at $5.00 per share.
Noah Doyle currently owns 704,780 shares of RITTER PHARMACEUTICALS INC (RTTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Noah Doyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Noah Doyle has 6 Form 4 filings on record as an insider at RITTER PHARMACEUTICALS INC.
Set alerts for Noah Doyle and 40,000+ other insiders.